Minerva Neurosciences
NERV
$2.37
Share price
-0.84%
Change (1 day)
-48.59%
Change (1 year)
Categories
Market capitalization of Minerva Neurosciences (NERV)
Market cap: $16.57 Million
As of May 2024 Minerva Neurosciences has a market cap of $16.57 Million. This makes Minerva Neurosciences the world's 8050th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Minerva Neurosciences from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $16.57 M | -61.46% |
| 2023 | $43 M | 406.54% |
| 2022 | $8.49 M | -75.19% |
| 2021 | $34.21 M | -65.77% |
| 2020 | $99.96 M | -64.03% |
| 2019 | $0.27 B | 5.89% |
| 2018 | $0.26 B | 12.09% |
| 2017 | $0.23 B | -42.75% |
| 2016 | $0.40 B | 172.55% |
| 2015 | $0.15 B | 35.18% |
| 2014 | $0.11 B |
End of Day market cap according to different sources
On May 4th, 2024 the market cap of Minerva Neurosciences was reported to be:
$16.57 Million
$16.57 Million
$16.57 Million
$16.57 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Incyte INCY | $12.07 B | 72,731.22% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | $1.53 B | 9,169.32% | 🇺🇸 USA |
 Clovis Oncology CLVS | $11.77 M | -28.98% | 🇺🇸 USA |